Biomea Fusion Inc (BMEA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.31M
Last updated: Nov 17, 2026 at 11:04 AM ET
Biomea Fusion Inc (BMEA) Stock Forecast
Analysts expect Biomea Fusion (BMEA) to earn -$0.62 per share in the fiscal year ending Dec 31, 2026. Of 7 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.14, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 86% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 28.6% |
| Buy | 4 | 57.1% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 14.3% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$0.62
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.91
- EPS consensus
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.62 | -$0.62 to -$0.62 | 1 |
| Dec 31, 2027 | -$0.91 | -$1.40 to -$0.50 | 3 |
Quarterly Estimates
The EPS consensus rises from -$0.29 for the quarter ending Dec 31, 2026 to -$0.12 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.29 | -$0.65 to -$0.17 | 9 |
| Mar 31, 2027 | -$0.12 | -$0.12 to -$0.12 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.84.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.62 | -$0.95 | -$0.84 | -$0.84 | -$0.84 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.91 | -$0.94 | -$0.94 | -$0.94 | -$0.94 | N/A |
| Quarter ending Mar 31, 2027 | -$0.12 | -$0.12 | -$0.12 | -$0.12 | -$0.15 | N/A |
Frequently Asked Questions About BMEA
What is the BMEA stock forecast?
Consensus analyst estimates put Biomea Fusion's EPS at -$0.62 for the fiscal year ending Dec 31, 2026. The consensus rating from 7 analysts is Buy.
How do analysts rate BMEA stock?
Of 7 analysts covering Biomea Fusion, 2 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from BMEA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.62, with estimates from -$0.62 to -$0.62 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.91, with estimates from -$1.40 to -$0.50 from 3 analysts.
How many analysts cover BMEA?
7 analysts rate Biomea Fusion stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
BMEA pages: Overview, Earnings, Forecast, Financials, Competitors